ReviewCancers2023

Neo-Adjuvant Treatment in Primary Resectable Pancreatic Cancer: A Systematic Review and PRISMA-Compliant Updated Metanalysis of Oncological Outcomes.

Raffaello Roesel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.